Xolair® (Omalizumab) Reduces Allergic Reactions in Multiple Food Allergies NEJM Phase III Data

Xolair® (Omalizumab) Reduces Allergic Reactions in Multiple Food Allergies: NEJM Phase III Data

Detailed results from the NIH-sponsored Phase III OUtMATCH study showed treatment with Xolair increased the amount of peanuts, tree nuts,…

Read More »